Efaroxan
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 2-(2-ethyl-2,3-dihydro-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Uncontrolled |
| Routes | Oral |
| Identifiers | |
| CAS number | 89197-32-0 |
| ATC code | None |
| PubChem | CID 72016 |
| ChemSpider | 65015  |
| UNII | G00490L21H |
| ChEMBL | CHEMBL57895 |
| Chemical data | |
| Formula | C13H16N2O |
| Mol. mass | 216.28 g/mol |
|
|
|
|
 (what is this?) (verify) |
|
Efaroxan is an α2-adrenergic receptor antagonist.[1]
[edit] See also
[edit] References
- ^ Chopin P, Colpaert FC, Marien M (February 1999). "Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway". J. Pharmacol. Exp. Ther. 288 (2): 798–804. PMID 9918591.
